Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Wiping out Akt3 protein can stall tumor development
National report — The Akt3 protein seems responsible for promoting tumor cell survival and development in 43 percent to 60 percent of noninherited melanomas. And wiping out the protein in melanoma cells could stall tumor development and increase the chemo-sensitivity of this traditionally chemo-resistant cancer, according to a new study.
Related Videos
Related Content
